Zobrazeno 1 - 7
of 7
pro vyhledávání: '"María Fernanda Lurbet"'
Autor:
Luis Patricio Maskin, Gabriel Leonardo Olarte, Fernando Palizas, Agostina E. Velo, María Fernanda Lurbet, Ignacio Bonelli, Natalio D. Baredes, Pablo Oscar Rodríguez
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-3 (2020)
Abstract Objectives The aim of this study is to explore the effectiveness and safety of high dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to SARS-Cov-2 pneumonia. Trial design Multicentre, randomized clinical trial,
Externí odkaz:
https://doaj.org/article/f7f3dfc1f92b46ae847c1dc63a5aad4f
Autor:
Luis Patricio Maskin, Ignacio Bonelli, Gabriel Leonardo Olarte, Fernando Palizas, Agostina E Velo, María Fernanda Lurbet, Pablo Lovazzano, Sophia Kotsias, Shiry Attie, Ignacio Lopez Saubidet, Natalio D Baredes, Mariano Setten, Pablo Oscar Rodriguez
Publikováno v:
Journal of Intensive Care Medicine. 37:491-499
Objective To determine whether high-dose dexamethasone increases the number of ventilator-free days (VFD) among patients with acute respiratory distress syndrome (ARDS) caused by COVID-19. Design Multicenter, randomized, open-label, clinical trial. P
Autor:
Ignacio, López Saubidet, Martín, Hunter, María Fernanda, Lurbet, Ignacio, Bonelli, Florencia, Mandó, Josefina, Parodi, Víctor, Torres, Fernando, Spernanzoni, Pablo O, Rodríguez
Publikováno v:
Medicina. 82(1)
Coronavirus disease 2019 (COVID-19) produces a significant burden to severely ill patients affected by acute respiratory failure. The aim of this study was to describe echocardiographic findings in a series of mechanically ventilated patients with mo
Autor:
Alfredo Martínez, Valeria Descalzi, Sebastián Marciano, María Fernanda Lurbet, Margarita Anders, Ezequiel Ridruejo, y Marcelo Silva, Nora Fernández, Adrián Gadano, Manuel Mendizabal, Fernando Gruz, Silvina Paz, Leila Haddad, Federico Orozco Ganem
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 126
Background Argentina is considered a region of low seroprevalence of hepatitis E virus (HEV), however; no studies have evaluated its burden among acute hepatitis cases. Objectives: We aimed to estimate the proportion of acute HEV and outcome in a coh
Autor:
Kattan, Eduardo1 e.kattan@gmail.com, Bakker, Jan2, Estenssoro, Elisa3, Ospina-Tascón, Gustavo Adolfo4, Cavalcanti, Alexandre Biasi5, De Backer, Daniel6, Vieillard-Baron, Antoine7, Teboul, Jean-Louis8, Castro, Ricardo1, Hernández, Glenn1
Publikováno v:
Revista Brasileira de Terapia Intensiva. Jan-Mar2022, Vol. 34 Issue 1, p96-106. 11p.
Autor:
Maskin, Luis Patricio, Bonelli, Ignacio, Olarte, Gabriel Leonardo, Palizas Jr., Fernando, Velo, Agostina E., Lurbet, María Fernanda, Lovazzano, Pablo, Kotsias, Sophia, Lopez Saubidet, Ignacio, Baredes, Natalio D., Setten, Mariano, Rodriguez, Pablo Oscar, Attie, Shiry
Publikováno v:
Journal of Intensive Care Medicine; Apr2022, Vol. 37 Issue 4, p491-499, 9p
Autor:
Maskin, Luis Patricio1,2 (AUTHOR) pmaskin@cemic.edu.ar, Olarte, Gabriel Leonardo3 (AUTHOR), Palizas, Fernando4 (AUTHOR), Velo, Agostina E.1 (AUTHOR), Lurbet, María Fernanda1 (AUTHOR), Bonelli, Ignacio1 (AUTHOR), Baredes, Natalio D.3 (AUTHOR), Rodríguez, Pablo Oscar1,2 (AUTHOR) prodriguez@cemic.edu.ar, Palizas, Fernando Jr4 (AUTHOR)
Publikováno v:
Trials. 8/26/2020, Vol. 21 Issue 1, pN.PAG-N.PAG. 1p.